Celularity (CELUW) Cash from Operations (2019 - 2025)
Celularity (CELUW) reported Cash from Operations of 5103000.0 for Q4 2025, down 420.14% year-over-year from 1594000.0 in Q4 2024, and down 22.7% quarter-over-quarter from 4159000.0 in Q3 2025.
Celularity (CELUW) Cash from Operations (2019 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of Cash from Operations data on file, last reported at 5103000.0 in Q4 2025.
- Cash from Operations for Q4 2025 came in at 5103000.0, down 420.14% year-over-year; the trailing twelve-month figure through Dec 2025 was 13254000.0 (down 107.06% YoY), and the FY2025 annual result was 13254000.0, down 107.06% from the prior year.
- Cash from Operations declined to 5103000.0 in Q4 2025 per CELUW's latest filing, from 4159000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 1594000.0 in Q4 2024 and troughed at 37720000.0 in Q3 2022.
- A 5-year average of 15315600.0 and a median of 9674500.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2021 and 2024: Cash from Operations plunged 8009.32% in 2021, then surged 136.72% in 2024.
- A 5-year view of Cash from Operations shows it stood at 32045000.0 in 2021, then increased by 7.68% to 29585000.0 in 2022, then jumped by 85.33% to 4341000.0 in 2023, then surged by 136.72% to 1594000.0 in 2024, then tumbled by 420.14% to 5103000.0 in 2025.
- Business Quant data shows CELUW's Cash from Operations at 5103000.0 in Q4 2025, 4159000.0 in Q3 2025, and 999000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Celularity | - | - | -3.27 Mn | -5.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.10 Mn |
| Dec 31, 2025 | -5.10 Mn |
| Sep 30, 2025 | -4.16 Mn |
| Sep 30, 2025 | -4.16 Mn |
| Jun 30, 2025 | -999,000.00 |
| Jun 30, 2025 | -999,000.00 |
| Mar 31, 2025 | -2.99 Mn |
| Mar 31, 2025 | -2.99 Mn |
| Dec 31, 2024 | 1.59 Mn |
| Dec 31, 2024 | 1.59 Mn |
| Sep 30, 2024 | -144,000.00 |
| Sep 30, 2024 | -144,000.00 |
| Jun 30, 2024 | -3.45 Mn |
| Jun 30, 2024 | -3.45 Mn |
| Mar 31, 2024 | -4.40 Mn |
| Mar 31, 2024 | -4.40 Mn |
| Dec 31, 2023 | -4.34 Mn |
| Dec 31, 2023 | -4.34 Mn |
| Sep 30, 2023 | -8.32 Mn |
| Sep 30, 2023 | -8.32 Mn |